The contribution of Langerhans cells to cutaneous malignancy

Trends in Immunology

Volumn 31, Issue 12, 2010, Pages 460-466

  Lewis, Julia ^a   Filler, Renata ^a   Smith, Debra A ^a   Golubets, Kseniya ^a   Girardi, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; CANCER RISK; CELL MIGRATION; CELL STRUCTURE; CHEMICAL CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; HUMAN; LANGERHANS CELL; MALIGNANT TRANSFORMATION; NONHUMAN; RADIATION CARCINOGENESIS; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR PROMOTION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADAPTIVE IMMUNITY; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LANGERHANS CELLS; MODELS, IMMUNOLOGICAL; SKIN NEOPLASMS;

EID: 78649633740     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.10.001     Document Type: Review

References (91)

1. Marchiando A.M., et al. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 2010, 5:119-144.
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001, 411:390-395.
3. Strid J., et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol. 2008, 9:146-154.
4. Kaplan D.H., et al. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005, 23:611-620.
5. Girardi M., et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001, 294:605-609.
6. Girardi M., et al. The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J. Exp. Med. 2003, 198:747-755.
7. Girardi M., et al. Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 2002, 195:855-867.
8. Girardi M., et al. Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta T cells. J. Invest. Dermatol. 2006, 126:808-814.
9. Strid J., et al. Skin immune surveillance by T cells-a new order?. Semin. Immunol. 2009, 21:110-120.
10. Randall T.D. Pulmonary dendritic cells: thinking globally, acting locally. J. Exp. Med. 2010, 207:451-454.
11. Flacher V., et al. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy. Cancer Immunol. Immunother. 2009, 58:1137-1147.
12. Nishibu A., et al. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J. Invest. Dermatol. 2006, 126:787-796.
13. Kubo A., et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J. Exp. Med. 2009, 206:2937-2946.
14. Anderson C., et al. Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J. Immunol. 1995, 155:3530-3537.
15. Bennett C.L., et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 2005, 169:569-576.
16. Kissenpfennig A., et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005, 22:643-654.
17. Abel E.L., et al. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc. 2009, 4:1350-1362.
18. Mastrangelo G., et al. Polycyclic aromatic hydrocarbons and cancer in man. Environ. Health Perspect. 1996, 104:1166-1170.
19. Esser C., et al. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009, 30:447-454.
20. Agostinis P. et al. (2007) The aryl hydrocarbon receptor: an illuminating effector of the UVB response. Sci STKE (403, pe49.
21. Jux B, et al. (2010) The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning. J. Invest. Dermatol. [Epub ahead of print].
22. Platzer B., et al. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 2009, 183:66-74.
23. Roberts S.J., et al. Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6770-6775.
24. Oppenheim D.E., et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 2005, 6:928-937.
25. Hennings H., et al. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis. 1993, 14:2353-2358.
26. Elmets C.A., et al. Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14915-14919.
27. Mantovani A., et al. Cancer-related inflammation. Nature 2008, 454:436-444.
28. Motswaledi M.H., Doman C. Lupus vulgaris with squamous cell carcinoma. J. Cutan. Pathol. 2007, 34:939-941.
29. Yerushalmi J., et al. Lupus vulgaris complicated by metastatic squamous cell carcinoma. Int. J. Dermatol. 1998, 37:934-935.
30. Gupta U., et al. Squamous cell carcinoma complicating an untreated chronic discoid lupus erythematosus (CDLE) lesion in a black female. J. Dermatol. 2005, 32:1010-1013.
31. Matsushita S., et al. Multiple squamous cell carcinomas arising in lesions of discoid lupus erythematosus. J. Dermatol. 2004, 31:73-75.
32. Daldon P.E., et al. Hypertrophic lupus erythematosus: a clinicopathological study of 14 cases. J. Cutan. Pathol. 2003, 30:443-448.
33. Kutlubay Z., et al. Squamous cell carcinoma arising from hypertrophic lichen planus. Eur. J. Dermatol. 2009, 19:175-176.
34. Krasowska D., et al. Development of squamous cell carcinoma within lesions of cutaneous lichen planus. Eur. J. Dermatol. 2007, 17:447-448.
35. Ebrahimi M., et al. Expression of novel p53 isoforms in oral lichen planus. Oral Oncol. 2008, 44:156-161.
36. Manz B., et al. Squamous cell carcinoma as a complication of long-standing hypertrophic lichen planus. Int. J. Dermatol. 2005, 44:773-774.
37. Carlson J.A., et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum. Pathol. 1998, 29:932-948.
38. Oke V., et al. High Ro52 expression in spontaneous and UV-induced cutaneous inflammation. J. Invest. Dermatol. 2009, 129:2000-2010.
39. Zheng D., et al. The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development. Cancer Res. 2008, 68:3992-3998.
40. Mühleisen B., et al. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 2009, 55:67-76.
41. Junankar S.R., et al. Analysis of immune cell infiltrates during squamous carcinoma development. J. Investig. Dermatol. Symp. Proc. 2006, 11:36-43.
42. Paz M.L., et al. Time-course evaluation and treatment of skin inflammatory immune response after ultraviolet B irradiation. Cytokine 2008, 44:70-77.
43. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
44. Fukunaga A. et al. (2010) Langerhans cells serve as immunoregulatory cells by activating NKT cells. J. Immunol. Sep 15 [Epub ahead of print].
45. Stoitzner P., et al. Langerhans cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7783-7788.
46. Kwong B., et al. Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carciongenesis. J. Invest. Dermatol. 2009, 130:1726-1736.
47. Woodard E. and Snedeker S. (2001) Polycyclic Aromatic Hydrocarbons. Program on Breast Cancer and Environmental Risk Factors. Sprecher Institute for Comparative Cancer Research, Fact Sheet #41.
48. Nelson M.A., et al. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:6398-6402. Erratum in: Proc. Natl. Acad. Sci. U. S. A. (1993) 90, 781.
49. Chen S.C., Liao C.M. Health risk assessment on human exposed to environmental polycyclic aromatic hydrocarbons pollution sources. Sci. Total Environ. 2006, 366:112-123.
50. Matsumoto Y., et al. Aryl hydrocarbon receptor plays a significant role in mediating airborne particulate-induced carcinogenesis in mice. Environ. Sci. Technol. 2007, 41:3775-3780.
51. Wang Y., et al. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin. Int. J. Cancer 2005, 116:193-199.
52. Fritsche E., et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8851-8856.
53. Pentland A.P., et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999, 20:1939-1944.
54. Zhang W., et al. UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis 2005, 26:249-257.
55. Zhang W., et al. Escaping the stem cell compartment: sustained UVB exposure allows p53-mutant keratinocytes to colonize adjacent epidermal proliferating units without incurring additional mutations. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:13948-13953.
56. Timares L., et al. DNA damage, apoptosis and langerhans cells-activators of UV-induced immune tolerance. Photochem. Photobiol. 2008, 84:422-436.
57. Nagao K., et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3312-3317.
58. Merad M., et al. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat. Rev. Immunol. 2008, 8:935-947.
59. Ginhoux F., et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 2007, 204:3133-3146.
60. Bayerl C., et al. Langerhans cells enclosing sunburn cells in acute UV erythema in vivo. Arch. Dermatol. Res. 1999, 291:303-305.
61. Fisher M.S., Kripke M.L. Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation. J. Immunol. 1978, 121:1139-1144.
62. Fisher M.S., Kripke M.L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 1977, 74:1688-1692.
63. Daynes R.A., et al. Phenotypic and physical characteristics of the lymphoid cells involved in the immunity to syngeneic UV-induced tumors. J. Immunol. 1979, 122:2458-2464.
64. Streilein J.W., et al. Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J. Invest. Dermatol. 1980, 74:319-322.
65. Noonan F.P., et al. Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. Immunology 1981, 43:527-533.
66. Elmets C.A., et al. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J. Exp. Med. 1983, 158:781-794.
67. Ullrich S.E., Kripke M.L. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J. Immunol. 1984, 133:2786-2790.
68. Moodycliffe A.M., et al. Immune suppression and skin cancer development: regulation by NKT cells. Nat. Immunol. 2000, 1:521-525.
69. Schwarz A., et al. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 2004, 172:1036-1043.
70. Bursch L.S., et al. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 2007, 204:3147-3156.
71. Poulin L.F., et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 2007, 204:3119-3131.
72. Wang L., et al. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J. Immunol. 2009, 183:5548-5553.
73. Schwarz A., et al. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 2010, 130:1419-1427.
74. Applegate L.A., et al. Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. J. Exp. Med. 1989, 170:1117-1131.
75. Vink A.A., et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:5255-5560.
76. Bouscarel B., et al. Regulation of stimulated cyclic AMP synthesis by urocanic acid. Photochem. Photobiol. 1998, 67:324-331.
77. Moodycliffe A.M., et al. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation. J. Immunol. 1996, 157:2891-2899.
78. Devary Y., et al. NF-kappa B activation by ultraviolet light is not dependent on a nuclear signal. Science 1993, 261:1442-1445.
79. Simon M.M., et al. UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J. Invest. Dermatol. 1994, 102:422-427.
80. Pei Y., et al. Activation of the epidermal platelet-activating factor receptor results in cytokine and cyclooxygenase-2 biosynthesis. J. Immunol. 1998, 161:1954-1961.
81. Kripke M.L., et al. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:7516-7520.
82. Walterscheid J.P., et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17420-17425.
83. Walterscheid J.P., et al. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J. Exp. Med. 2002, 195:171-179.
84. El-Ghorr A.A., Norval M. A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. J. Invest. Dermatol. 1995, 105:264-268.
85. Beissert S., et al. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis. J. Immunol. 2001, 167:6232-6238.
86. Sreevidya C.S., et al. Agents that reverse UV-Induced immune suppression and photocarcinogenesis affect DNA repair. J. Invest. Dermatol. 2010, 130:1428-1437.
87. Schwarz A., et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat. Cell Biol. 2002, 4:26-31.
88. Schwarz A., et al. Prevention of UV radiation-induced immunosuppression by IL-12 is dependent on DNA repair. J. Exp. Med. 2005, 201:173-179.
89. Schwarz A., et al. IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression. J. Immunol. 2006, 176:2896-2901.
90. Sontag Y., et al. Cells with UV-specific DNA damage are present in murine lymph nodes after in vivo UV irradiation. J. Invest. Dermatol. 1995, 104:734-738.
91. Maeda A., et al. Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J. Immunol. 2008, 180:3065-3071.